Pacific Biosciences of California, Inc.
PACB· Nasdaq
PACBPacific Biosciences of California, Inc.
Released Feb 10, 2021, after the close
10-K filed Feb 26, 2021, 57 days after period end · 0001299130-21-000098
derived · Computed from the longer spans the company filed.
| Metric | Q4 2020dderived from reported figures | Q4 2019 | Q4 2018 | Q4 2017 |
|---|---|---|---|---|
| Revenue | $25.13M | $27.93M | $19.53M | $24.94M |
| Net Income | $74.94M | -$91.00K | -$30.80M | -$20.76M |
Pacific Biosciences of California, Inc. · CIK 1299130 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
